:: jbc :: journal of breast cancer · methods: since nov. 1998, when docetaxel gained korean...

8

Upload: others

Post on 19-Aug-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: :: JBC :: Journal of Breast Cancer · Methods: Since Nov. 1998, when docetaxel gained Korean approval in the treatment of breast cancer, Tel: 02—527-5239. Fax: 02—527--057. E-mail:
Page 2: :: JBC :: Journal of Breast Cancer · Methods: Since Nov. 1998, when docetaxel gained Korean approval in the treatment of breast cancer, Tel: 02—527-5239. Fax: 02—527--057. E-mail:
Page 3: :: JBC :: Journal of Breast Cancer · Methods: Since Nov. 1998, when docetaxel gained Korean approval in the treatment of breast cancer, Tel: 02—527-5239. Fax: 02—527--057. E-mail:
Page 4: :: JBC :: Journal of Breast Cancer · Methods: Since Nov. 1998, when docetaxel gained Korean approval in the treatment of breast cancer, Tel: 02—527-5239. Fax: 02—527--057. E-mail:
Page 5: :: JBC :: Journal of Breast Cancer · Methods: Since Nov. 1998, when docetaxel gained Korean approval in the treatment of breast cancer, Tel: 02—527-5239. Fax: 02—527--057. E-mail:
Page 6: :: JBC :: Journal of Breast Cancer · Methods: Since Nov. 1998, when docetaxel gained Korean approval in the treatment of breast cancer, Tel: 02—527-5239. Fax: 02—527--057. E-mail:
Page 7: :: JBC :: Journal of Breast Cancer · Methods: Since Nov. 1998, when docetaxel gained Korean approval in the treatment of breast cancer, Tel: 02—527-5239. Fax: 02—527--057. E-mail:
Page 8: :: JBC :: Journal of Breast Cancer · Methods: Since Nov. 1998, when docetaxel gained Korean approval in the treatment of breast cancer, Tel: 02—527-5239. Fax: 02—527--057. E-mail: